Cardinal Health, Inc.
Compare market positioning with top industry peers
Explore Cardinal Health
Core profile pages, annual revenue records, and related research hubs for this company.
Financial Performance
Revenue
$222.6B
Market Cap
$28.4B
Net Income
$1.6B
Employees
48,000
Cardinal Health operates as one of the three foundational, indispensable pillars of the US pharmaceutical supply chain. Under CEO Jason Hollar, the distribution giant generated a staggering $225.8 billion in revenue and maintains a $28.4 billion market cap with exactly 48000 employees. The financial narrative in 2026 is characterized by high-volume, razor-thin margin revenue driven entirely by the explosive, insatiable national demand for GLP-1 weight-loss drugs (Wegovy, Zepbound) and expensive specialty biologics. To combat the inherently low margins of drug distribution, Cardinal Health is investing capital into its Medical segment, attempting to improve profitability through the rollout of its proprietary, high-margin at-home healthcare products.
Revenue Trend Analysis
YoY Change
-1.9%
3-Year CAGR
+7.1%
Peak Year
2024
Trend
Mostly Growing
Cardinal Health, Inc. has reported revenue across 4 fiscal years, compounding at +7.1% annually over 3 years. The most recent year saw a 1.9% decline versus the prior year. Revenue peaked in 2024 at $226.8B. Out of 3 reported periods, 2 showed growth and 1 showed a decline.
| Fiscal Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2025 | $222.6B | $1.6B | -1.9% |
| FY2024 | $226.8B | $853M | +10.7% |
| FY2023 | $205.0B | $331M | +13.0% |
| FY2022 | $181.3B | — | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.
Click any row to see year details.
Cardinal Health, Inc. reported approximately $225.8B in fiscal year 2025 with a team of 48,000 employees worldwide.
Cardinal Health, Inc. strategically balances reinvestment into core R&D with operational cost discipline, focusing on workflow automation to expand operating margins in 2026.
Financial performance in Healthcare Distribution / Medical Distribution is driven by steady cash generation and pricing power, enabling Cardinal Health, Inc. to reinvest in high-return strategic initiatives.
Using these figures? Please credit CorpDigest with a link.
CorpDigest. "Cardinal Health, Inc. Revenue & Financials." CorpDigest, https://corpdigest.com/company/cardinal-health/financials.<div style="font-family:system-ui,sans-serif;font-size:14px;line-height:1.5;border:1px solid #e2e8f0;border-radius:8px;padding:12px 16px;max-width:520px"><strong>Cardinal Health, Inc. reported $223B in revenue (FY2025).</strong><br>Source: <a href="https://corpdigest.com/company/cardinal-health/financials" target="_blank" rel="noopener">CorpDigest — Cardinal Health, Inc. financials</a></div>